3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
10
Phase 2
3
Phase 4
1
Phase 3
1
Phase 1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
583
Lymphoid
583
Myeloid
183
Dermatologic
97
Plasma cell
93
Sarcoma
59
Classical hematology
36
CNS
28
Genitourinary
23
Breast
20
Gynecologic
18
Gastrointestinal
18
Thoracic
14
Other neoplasm
12
Head & Neck
5
Endocrine
3
Other solid neoplasm
2
Other
1
Conditions
Mucositis
7
Obesity
6
Polycystic Ovary Syndrome
3
Stomatitis
2
Head and Neck Neoplasms
2
Tongue Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Mouth Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Lung Neoplasms
1
Lipid Metabolism Disorders
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Hodgkin Disease
1
Hirsutism
1
Endometrial Neoplasms
1
Dyspnea
1
Drug-Related Side Effects and Adverse Reactions
1
Disease
1
Diabetes Mellitus
1
Colorectal Neoplasms
1
Interventions
angiotensin I (1-7)
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Other
×
Clear all
NCT01300611
2020-12-08
USBTXA127CBT
Tarix Pharmaceuticals
Phase 1
Terminated
20 enrolled